Patient Outcomes in Resected Combined Hepatocellular Cholangiocarcinoma (cHCC-ICC) and Intrahepatic Cholangiocarcinoma: A Single Center Study
Rick Y. Lin, Doga Kahramangil, Muhammet Ozer, Thomas J. George, Ibrahim Nassour, Steven J. Hughes, Ali Zarrinpar, Ilyas Sahin · 2024
Read Patient Outcomes in Resected Combined Hepatocellular Cholangiocarcinoma (cHCC-ICC) and Intrahepatic Cholangiocarcinoma: A Single Center Study by Rick Y. Lin, Doga Kahramangil, Muhammet Ozer, Thomas J. George, Ibrahim Nassour, Steven J. Hughes, Ali Zarrinpar, Ilyas Sahin (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11592994.txt.
Description
Lin and co-authors compare outcomes after surgery for two related liver cancers at one center. One is a mixed tumor joining liver cell and bile duct features. It runs a more aggressive course, yet its risks were ill defined. Records covered 82 patients operated from 2011 to 2023. Seventy had the pure bile duct cancer of the liver; 12 had the mixed form. Overall survival for all was 21.6 months, with 11.8 months free of recurrence.
The mixed group showed far higher liver enzyme levels at baseline. Survival and recurrence patterns were set side by side. The small mixed group limits firm claims, but the contrast guides follow-up care.
Catalog record
| CREATOR | Rick Y. Lin, Doga Kahramangil, Muhammet Ozer, Thomas J. George, Ibrahim Nassour, Steven J. Hughes, Ali Zarrinpar, Ilyas Sahin |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 24 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |